Press releases

2008-12-11Abstral receives marketing approval in Germany
2008-11-10Orexo AB (publ) – Interim report January-September 2008
2008-10-31Orexo and ProStrakan advance date for taking over rights for Rapinyl in North America
2008-10-23Nomination Committee prior to Orexo’s 2009 Annual General Meeting
2008-09-23UK Marketing Approval Issued for Abstral
2008-09-08Orexo and Boehringer Ingelheim extend their research collaboration
2008-09-02Orexo initiates clinical phase II program for OX914 - a new product candidate for the treatment of inflammatory airway diseases
2008-08-14Interim report January-June 2008
2008-08-01Correction to the press release regarding sales milestone payments in Europe in connection with the new Licensing Agreement with ProStrakan
2008-08-01New sales milestone payments in Europe in connection with the new Licensing Agreement with ProStrakan
2008-07-31Orexo and ProStrakan Extend Licensing Agreement for Rapinyl/Abstral and change Partner in North America
2008-07-29The FDA has accepted for filing the registration application for Sublinox™
2008-06-26Orexo report Abstral (Rapinyl) approval in Europe
2008-06-09Orexo strengthens the Executive Management Group
2008-05-15Orexo has submitted the registration application (NDA) for Sublinox™ (OX22) to the FDA on May 14 2008
2008-05-12Orexo to present at Rodman & Renshaw 5th Annual Global Healthcare Conference
2008-05-12Orexo to present at BioEquity Europe 2008
2008-05-07Interim Report January-March 2008
2008-04-29Orexo reports positive results from phase I study for OX19
2008-04-14Orexo and Meda in a potential billion SEK deal
2008-04-03Report from Orexo AB’s Annual General Meeting, April 3, 2008
2008-03-27Orexo announces results confirming the clinical profile of OX17 in reflux disease (GERD)
2008-03-18Orexo’s product NLA Nasal Spray shows excellent local tolerability in patients with rhinitis
2008-03-07Rapinyl™ has received Swedish Marketing Authorization
2008-03-04Notice of Annual General Meeting in Orexo AB
2008-02-15Year-end Report January - December 2007
2008-01-15Orexo AB – Financial calendar 2008
2008-01-10Orexo discloses new mechanism for asthma and COPD treatment